These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 11561218)

  • 21. Transmission of high-risk HLA-DQB1 alleles in Chilean type 1 diabetic patients and their parents: stratification by the presence of ICA or GAD65 autoantibodies.
    Pérez-Bravo F; Santos JL; Carrasco E; Calvillán M; Albala C; Puig-Domingo M; Piquer S; De Leiva A
    Autoimmunity; 2001; 33(4):285-91. PubMed ID: 11683403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiplicity of the antibody response to GAD65 in Type I diabetes.
    Gilliam LK; Binder KA; Banga JP; Madec AM; Ortqvist E; Kockum I; Luo D; Hampe CS
    Clin Exp Immunol; 2004 Nov; 138(2):337-41. PubMed ID: 15498046
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Naturally processed T cell epitopes from human glutamic acid decarboxylase identified using mice transgenic for the type 1 diabetes-associated human MHC class II allele, DRB1*0401.
    Wicker LS; Chen SL; Nepom GT; Elliott JF; Freed DC; Bansal A; Zheng S; Herman A; Lernmark A; Zaller DM; Peterson LB; Rothbard JB; Cummings R; Whiteley PJ
    J Clin Invest; 1996 Dec; 98(11):2597-603. PubMed ID: 8958223
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Low agreement between radio binding assays in analyzing glutamic acid decarboxylase (GAD65Ab) autoantibodies in patients classified with type 2 diabetes.
    Daka B; Svensson MK; Lernmark K; Mincheva-Nilsson L; Hallmans G; Rolandsson O
    Autoimmunity; 2009 Sep; 42(6):507-14. PubMed ID: 19657779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent GAD 65 antibodies in longstanding IDDM are not associated with residual beta-cell function, neuropathy or HLA-DR status.
    Jaeger C; Allendörfer J; Hatziagelaki E; Dyrberg T; Bergis KH; Federlin K; Bretzel RG
    Horm Metab Res; 1997 Oct; 29(10):510-5. PubMed ID: 9405979
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Antibody responses to deamidated gliadin peptide show high specificity and parallel antibodies to tissue transglutaminase in developing coeliac disease.
    Ankelo M; Kleimola V; Simell S; Simell O; Knip M; Jokisalo E; Tarkia M; Westerlund A; He Q; Viander M; Ilonen J; Hinkkanen AE
    Clin Exp Immunol; 2007 Nov; 150(2):285-93. PubMed ID: 17803713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA-DRB1 alleles contribute to determining the prognosis of Japanese diabetes mellitus positive for antibodies to glutamate decarboxylase.
    Fukui M; Nakano K; Nakamura N; Maruya E; Saji H; Obayashi H; Ohta K; Ohta M; Mori H; Kajiyama S; Wada S; Kida Y; Kosaka K; Deguchi M; Shigeta H; Kitagawa Y; Kondo M
    J Clin Immunol; 1998 Jan; 18(1):89-92. PubMed ID: 9475358
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunoglobulin subclass profiles of anti-idiotypic antibodies to GAD65Ab differ between type 1 diabetes patients and healthy individuals.
    Oak S; Radtke J; Törn C; Landin-Olsson M; Hampe CS
    Scand J Immunol; 2011 Oct; 74(4):363-7. PubMed ID: 21517929
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Newly diagnosed latent autoimmune diabetes in adults (LADA) is associated with low level glutamate decarboxylase (GAD65) and IA-2 autoantibodies. Diabetes Incidence Study in Sweden (DISS).
    Schranz DB; Bekris L; Landin-Olsson M; Törn C; Niläng A; Toll A; Sjöström J; Grönlund H; Lernmark A
    Horm Metab Res; 2000 Apr; 32(4):133-8. PubMed ID: 10824708
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoantibody recognition of COOH-terminal epitopes of GAD65 marks the risk for insulin requirement in adult-onset diabetes mellitus.
    Falorni A; Gambelunghe G; Forini F; Kassi G; Cosentino A; Candeloro P; Bolli GB; Brunetti P; Calcinaro F
    J Clin Endocrinol Metab; 2000 Jan; 85(1):309-16. PubMed ID: 10634404
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Timing of initial cereal exposure in infancy and risk of islet autoimmunity.
    Norris JM; Barriga K; Klingensmith G; Hoffman M; Eisenbarth GS; Erlich HA; Rewers M
    JAMA; 2003 Oct; 290(13):1713-20. PubMed ID: 14519705
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HLA-associated cellular response to GAD in type 2 diabetes with antibodies to GAD.
    Fukui M; Nakamura N; Nakano K; Kajiyama S; Matsuo S; Obayashi H; Ohta M; Shigeta M; Shigeta H; Kitagawa Y; Kondo M
    Endocr J; 2000 Dec; 47(6):753-61. PubMed ID: 11228050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoantibodies against glutamic acid decarboxylase 65 in Japanese patients with insulin-dependent diabetes mellitus (IDDM).
    Yano M; Moriuchi R; Kawasaki E; Watanabe M; Saito K; Takino H; Akazawa S; Miyamoto T; Nagataki S
    J Autoimmun; 1995 Feb; 8(1):83-96. PubMed ID: 7734039
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Prevalence and predictive value of islet cell autoantibodies and anti-glutamic acid decarboxylase in a family study in Lyons].
    Thivolet C
    Journ Annu Diabetol Hotel Dieu; 1992; ():165-71. PubMed ID: 1495236
    [No Abstract]   [Full Text] [Related]  

  • 35. Clinical and genetic characteristics of diabetic patients with high-titer (>10,000 U/ml) of antibodies to glutamic acid decarboxylase.
    Ishii M; Hasegawa G; Fukui M; Obayashi H; Ohta M; Ogata M; Yoshioka K; Kitagawa Y; Nakano K; Yoshikawa T; Nakamura N
    Immunol Lett; 2005 Jul; 99(2):180-5. PubMed ID: 16009268
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Islet autoantibodies in cord blood from children who developed type I (insulin-dependent) diabetes mellitus before 15 years of age.
    Lindberg B; Ivarsson SA; Landin-Olsson M; Sundkvist G; Svanberg L; Lernmark A
    Diabetologia; 1999 Feb; 42(2):181-7. PubMed ID: 10064098
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early epitope- and isotype-specific humoral immune responses to GAD65 in young children with genetic susceptibility to type 1 diabetes.
    Ronkainen MS; Hoppu S; Korhonen S; Simell S; Veijola R; Ilonen J; Simell O; Knip M
    Eur J Endocrinol; 2006 Oct; 155(4):633-42. PubMed ID: 16990664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal changes in epitope recognition of autoantibodies against glutamate decarboxylase 65 (GAD65Ab) in prediabetic adults developing diabetes.
    Hampe CS; Hall TR; Agren A; Rolandsson O
    Clin Exp Immunol; 2007 Apr; 148(1):72-8. PubMed ID: 17286757
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Development of glutamic acid decarboxylase 65 (GAD65) autoantibody assay using biotin-GAD65 fusion protein.
    Luo D; Rogers CN; Steed JT; Gilliam LK; Hampe CS; Lernmark A
    J Biotechnol; 2004 Jul; 111(1):97-104. PubMed ID: 15196774
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Accuracy of testing for antibodies to synthetic gliadin-related peptides in celiac disease.
    Sugai E; Vázquez H; Nachman F; Moreno ML; Mazure R; Smecuol E; Niveloni S; Cabanne A; Kogan Z; Gómez JC; Mauriño E; Bai JC
    Clin Gastroenterol Hepatol; 2006 Sep; 4(9):1112-7. PubMed ID: 16860613
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.